Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 22,561,000 | 20,776,000 | 19,427,000 | 16,560,000 | 15,879,000 |
| Cost of Goods | 6,467,000 | 6,014,000 | 4,969,000 | 3,909,000 | 3,932,000 |
| Gross Profit | 16,094,000 | 14,762,000 | 14,458,000 | 12,651,000 | 11,947,000 |
| Operating Expenses | 10,126,000 | 9,631,000 | 8,543,000 | 10,574,000 | 9,566,000 |
| Operating Income | 5,968,000 | 5,131,000 | 5,915,000 | 2,077,000 | 2,381,000 |
| Pre-tax Income | 5,968,000 | 5,131,000 | 5,915,000 | 2,077,000 | 2,381,000 |
| Income Tax | 1,021,000 | 4,156,000 | 1,408,000 | 446,000 | 352,000 |
| Net Income Continuous | 4,947,000 | 975,000 | 4,507,000 | 1,631,000 | 2,029,000 |
| Minority Interests | 27,000 | -32,000 | 50,000 | 66,000 | 25,000 |
| Net Income | $4,920,000 | $1,007,000 | $4,457,000 | $1,565,000 | $2,004,000 |
| EPS Basic Total Ops | 3.01 | 0.61 | 2.67 | 0.94 | 1.21 |
| EPS Basic Continuous Ops | 3.03 | 0.59 | 2.70 | 0.98 | 1.22 |
| EPS Diluted Total Ops | 3.01 | 0.61 | 2.65 | 0.93 | 1.20 |
| EPS Diluted Continuous Ops | 3.02 | 0.59 | 2.68 | 0.97 | 1.22 |
| EPS Diluted Before Non-Recurring Items | 3.98 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $6,605,000 | $5,920,000 | $6,297,000 | $2,453,000 | $2,848,000 |